Skip to main content

Advertisement

SpringerLink
Log in

The paradox of pro-inflammatory cytokines in cancer

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Cytokines such as IL-1 and TNF are primarily pro-inflammatory. The inflammation induced by these cytokines is reflected in the type of genes they induce. In the pathogenesis of carcinogenesis as well as tumor growth and spread, cytokines such as IL-1 and TNF induce chemokines that attract neutrophils. Neutrophils are key players in the production of reactive oxygen species and carcinogenesis. Another aspect of pro-inflammatory cytokines is the induction of adhesion molecules and metalloproteinases, both of which provide mechanisms for tumor invasion. Blocking cytokines, however, will reduce tumor growth and spread if administered at sufficient concentrations and will require parenteral therapy. However, blocking cytokines will not kill tumor cells nor prevent carcinogenesis. Blocking cytokines is best as an adjunct therapy together with tumorocidal drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. van Denventer, S. J. H. (2001). Transmembrane TNFα, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's Disease. Gastroenterology, 121, 1242–1246.

    Article  Google Scholar 

  2. Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G. R., Tesser, J., et al. (2003). Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis & Rheumatism, 48, 927–934.

    Article  CAS  Google Scholar 

  3. Mohan, A. K., Cote, T. R., Block, J. A., Manadan, A. M., Siegel, J., & Braun, M. M. (2004). Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clinical Infectious Diseases, 39, 295–299.

    Article  CAS  PubMed  Google Scholar 

  4. Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., & Beenhouwer, D. O. (2004). Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clinical Infectious Diseases, 38, 1261–1265.

    Article  CAS  PubMed  Google Scholar 

  5. Wallis, R. S., Saliu, O. Y., Sofer, C., Stein, D. S., & Schwander, S. K. (2005). Differential effects of TNF blockers on TB immunity. Annals of the Rheumatic Diseases, 64(suppl 3), 132.

    Google Scholar 

  6. Balkwill, F., Charles, K. A., & Mantovani, A. (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 7, 211–217.

    Article  CAS  PubMed  Google Scholar 

  7. Mantovani, A. (2005). Cancer: Inflammation by remote control. Nature, 435, 752–753.

    Article  CAS  PubMed  Google Scholar 

  8. Colombo, M. P., & Mantovani, A. (2005). Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Research, 65, 9113–9116.

    Article  CAS  PubMed  Google Scholar 

  9. El-Omar, E. M., Carrington, M., Chow, W. H., McColl, K. E., Bream, J. H., Young, H. A., et al. (2001). The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature, 412, 99.

    Article  CAS  PubMed  Google Scholar 

  10. Glas, J., Torok, H. P., Schneider, A., Brunnler, G., Kopp, R., Albert, E. D., et al. (2004). Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. Journal of Clinical Oncology, 22, 4746–4752.

    Article  CAS  PubMed  Google Scholar 

  11. Hamajiama, N., Matsuo, K., Saito, T., Tajima, K., Okujma, K., Yamao, K., et al. (2001). Interleukin-1 polymorphims, lifestyle factors and Helicobacter pylori infection. Japanese Journal of Cancer Research, 92, 383–389.

    Google Scholar 

  12. Riedel, S., Kraft, M., Kucharzik, T., Pauels, H. G., Tiemann, M., Steinbuchel, A., et al. (2001). CD4+ Th1-cells predominate in low-grade B-cell lymphoma of gastric mucosa-associated lymphoid tissue (MALT type). Scandinavian Journal of Gastroenterology, 36, 1198–1203.

    Article  CAS  PubMed  Google Scholar 

  13. Gatti, L. L., Burbano, R. R., de Assumpcao, P. P., Smith Mde, A., & Payao, S. L. (2004). Interleukin-1beta polymorphisms, Helicobacter pylori infection in individuals from Northern Brazil with gastric adenocarcinoma. Clinical and Experimental Medicine, 4, 93–98.

    Article  PubMed  CAS  Google Scholar 

  14. Chang, Y. W., Jang, J. Y., Kim, N. H., Lee, J. W., Lee, H. J., Jung, W. W., et al. (2005). Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. International Journal of Cancer, 114, 465–471.

    Article  CAS  Google Scholar 

  15. Chandrasekharan, N. V., Dai, H., Roos, K. L., Evanson, N. K., Tomsik, J., Elton, T. S., et al. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proceedings of the National Academy of Sciences of the United States of America, 99, 13926–13931.

    Article  CAS  PubMed  Google Scholar 

  16. Dinarello, C. A. (1996). Biological basis for interleukin-1 in disease. Blood, 87, 2095–2147.

    CAS  PubMed  Google Scholar 

  17. Li, S., Ballou, L. R., Morham, S. G., & Blatteis, C. M. (2001). Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Research, 910, 163–173.

    Article  CAS  PubMed  Google Scholar 

  18. Li, S., Goorha, S., Ballou, L. R., & Blatteis, C. M. (2003). Intracerebroventricular interleukin-6, macrophage inflammatory protein-1 beta and IL-18: Pyrogenic and PGE(2)-mediated? Brain Research, 992, 76–84.

    Article  CAS  PubMed  Google Scholar 

  19. Li, S., Wang, Y., Matsumura, K., Ballou, L. R., Morham, S. G., & Blatteis, C. M. (1999). The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(−/−), but not in cyclooxygenase-1(−/−) mice. Brain Research, 825, 86–94.

    Article  CAS  PubMed  Google Scholar 

  20. Di Mari, J. F., Mifflin, R. C., Adegboyega, P. A., Saada, J. I., & Powell, D. W. (2003). IL-1alpha-induced COX-2 expression in human intestinal myofibroblasts is dependent on a PKCzeta-ROS pathway. Gastroenterology, 124, 1855–1865.

    Article  PubMed  CAS  Google Scholar 

  21. Netea, M. G., Puren, A. J., & Dinarello, C. A. (2000). A short course of oral aspirin increases IL-18-induced interferon-gamma production in whole blood cultures. European Cytokine Network, 11, 379–382.

    CAS  PubMed  Google Scholar 

  22. Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., et al. (2003). IL-1 is required for tumor invasiveness and angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 100, 2645–2650.

    Article  CAS  PubMed  Google Scholar 

  23. Jung, Y. J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003). IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. Faseb Journal, 17, 2115–2117.

    CAS  PubMed  Google Scholar 

  24. Konturek, P. C., Kania, J., Konturek, J. W., Nikiforuk, A., Konturek, S. J., & Hahn, E. G. (2003). H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. Medical Science Monitor, 9, SR53–SR66.

    CAS  PubMed  Google Scholar 

  25. Carrascal, M. T., Mendoza, L., Valcarcel, M., Salado, C., Egilegor, E., Telleria, N., et al. (2003). Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Research, 63, 491–497.

    CAS  PubMed  Google Scholar 

  26. Vidal-Vanaclocha, F., Fantuzzi, G., Mendoza, L., Fuentes, A. M., Anasagasti, M. J., Martin, J., et al. (2000). IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proceedings of the National Academy of Sciences of the United States of America, 97, 734–739.

    Article  CAS  PubMed  Google Scholar 

  27. Lee, J. K., Kim, S. H., Lewis, E. C., Azam, T., Reznikov, L. L., & Dinarello, C. A. (2004). Differences in signaling pathways by IL-1beta and IL-18. Proceedings of the National Academyof Sciences of the United States of America, 101, 8815–8820.

    Article  CAS  Google Scholar 

  28. Dinarello, C. A., Cannon, J. G., Mancilla, J., Bishai, I., Lees, J., & Coceani, F. (1991). Interleukin-6 as an endogenous pyrogen: Induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Research, 562, 199–206.

    Article  CAS  PubMed  Google Scholar 

  29. Reznikov, L. L., Kim, S. H., Westcott, J. Y., Frishman, J., Fantuzzi, G., Novick, D., et al. (2000). IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. Proceedings of the National Academy of Sciences of the United States of America, 97, 2174–2179.

    Google Scholar 

  30. Borrello, M. G., Alberti, L., Fischer, A., Degl'innocenti, D., Ferrario, C., Gariboldi, M., et al. (2005). Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proceedings of the National Academy of Sciences of the United States of America, 102, 14825–14830.

    Article  CAS  PubMed  Google Scholar 

  31. Zou, J., Rudwaleit, M., Brandt, J., Thiel, A., Braun, J., & Sieper, J. (2003). Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Arthritis & Rheumatism, 48, 780–790.

    Article  CAS  Google Scholar 

  32. Zou, J., Rudwaleit, M., Brandt, J., Thiel, A., Braun, J., & Sieper, J. (2003). Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept. Annals of the Rheumatic Diseases, 62, 561–564.

    Article  CAS  PubMed  Google Scholar 

  33. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., et al. (2001). Tuberculosis associated with infliximab, a tumor necrosis factor-α-neutralizing agent. New England Journal of Medicine, 345, 1098–1104.

    Article  CAS  PubMed  Google Scholar 

  34. Brown, S. L., Greene, M. H., Gershon, S. K., Edwards, E. T., & Braun, M. M. (2002). Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration. Arthritis & Rheumatism, 46, 3151–3158.

    Article  CAS  Google Scholar 

  35. Song, X., Krelin, Y., Dvorkin, T., Bjorkdahl, O., Segal, S., Dinarello, C. A., et al. (2005). CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1β-secreting Cells. Journal of Immunology, 175, 8200–8208.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Infectious Diseases, University of Colorado Health Sciences Center, 4200 East Ninth Ave., B168, Denver, CO, 80262, USA

    Charles A. Dinarello

Authors
  1. Charles A. Dinarello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles A. Dinarello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dinarello, C.A. The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 25, 307–313 (2006). https://doi.org/10.1007/s10555-006-9000-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-006-9000-8

Keywords

Search

Navigation